Brave Asset Management Inc Becton Dickinson & CO Transaction History

Brave Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$232.24 - $267.23 $5,109 - $5,879	22 Added 2.2%	1,022 $249,000
Q1 2022 Apr 22, 2022	SELL	$243.64 - $270.48 $2,680 - $2,975	-11 Reduced 1.09%	1,000 $266,000
Q4 2021 Jan 21, 2022	SELL	$230.08 - $250.94 $2,300 - $2,509	-10 Reduced 0.98%	1,011 $254,000
Q3 2021 Nov 02, 2021	BUY	$232.72 - $256.47 $4,887 - $5,385	21 Added 2.1%	1,021 $251,000
Q4 2019 Jan 17, 2020	SELL	$236.45 - $266.82 $12,058 - $13,607	-51 Reduced 4.85%	1,000 $272,000
Q2 2019 Aug 05, 2019	BUY	$217.4 - $246.08 $2,608 - $2,952	12 Added 1.15%	1,051 $265,000
Q2 2018 Jul 23, 2018	SELL	$208.1 - $233.85 $1.01 Million - $1.13 Million	-4,849 Reduced 82.35%	1,039 $249,000
Q1 2018 Apr 26, 2018	BUY	$205.46 - $240.27 $1.21 Million - $1.41 Million	5,888 New	5,888 $1.28 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Brave Asset Management Inc with notifications on news.